We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
PUT
Texas Instruments
TXN
$255B
| $271K | ﹤0.01% |
+1,900
| New | +$258K |
|
|
MODN
1877
DELISTED
MODEL N, INC.
MODN
| $271K | ﹤0.01% |
+7,668
| New | +$290K |
|
|
RAD
1878
DELISTED
Rite Aid Corporation
RAD
| $271K | ﹤0.01% |
+28,562
| New | +$408K |
|
1879
Altimmune
ALT
$539M
| $270K | ﹤0.01% |
+20,427
| New | +$408K |
|
1880
Trinity Industries
TRN
$2.97B
| $270K | ﹤0.01% |
13,831
-7,668
| -36% | -$156K |
|
1881
Acadia Realty Trust
AKR
$2.99B
| $269K | ﹤0.01% |
25,613
+5,420
| +27% | +$64.8K |
|
1882
Stereotaxis
STXS
$129M
| $269K | ﹤0.01% |
75,015
+64,244
| +596% | +$248K |
|
|
RUBY
1883
DELISTED
Rubius Therapeutics, Inc
RUBY
| $269K | ﹤0.01% |
53,710
+24,308
| +83% | +$129K |
|
1884
Delek US
DK
$3.87B
| $268K | ﹤0.01% |
24,077
-20,819
| -46% | -$320K |
|
1885
McGrath RentCorp
MGRC
$2.94B
| $268K | ﹤0.01% |
4,494
-5,046
| -53% | -$304K |
|
|
SMED
1886
DELISTED
Sharps Compliance Corp
SMED
| $268K | ﹤0.01% |
42,766
+27,072
| +172% | +$197K |
|
1887
ImmunityBio
IBRX
$7.44B
| $267K | ﹤0.01% |
38,571
+26,194
| +212% | +$261K |
|
|
KLDO
1888
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $267K | ﹤0.01% |
+24,088
| New | +$167K |
|
1889
CALL
Chevron
CVX
$388B
| $266K | ﹤0.01% |
+3,700
| New | +$311K |
|
|
1890
PUT
Chevron
CVX
$388B
| $266K | ﹤0.01% |
+3,700
| New | +$311K |
|
|
INN
1891
Summit Hotel Properties
INN
$761M
| $266K | ﹤0.01% |
51,267
+40,934
| +396% | +$231K |
|
1892
CALL
Eli Lilly
LLY
$1.07T
| $266K | ﹤0.01% |
1,800
+500
| +38% | +$77.4K |
|
|
1893
PUT
Eli Lilly
LLY
$1.07T
| $266K | ﹤0.01% |
1,800
+500
| +38% | +$77.4K |
|
|
LPRO
1894
Open Lending Corp
LPRO
$373M
| $266K | ﹤0.01% |
+10,446
| New | +$203K |
|
1895
Everspin Technologies
MRAM
$354M
| $266K | ﹤0.01% |
+46,916
| New | +$299K |
|
1896
Veracyte
VCYT
$4.52B
| $266K | ﹤0.01% |
8,196
-3,263
| -28% | -$104K |
|
|
CLDT
1897
Chatham Lodging
CLDT
$630M
| $265K | ﹤0.01% |
34,832
-69,132
| -66% | -$453K |
|
1898
Relay Therapeutics
RLAY
$4.02B
| $265K | ﹤0.01% |
+6,212
| New | +$237K |
|
|
TPIC
1899
DELISTED
TPI Composites
TPIC
| $265K | ﹤0.01% |
9,135
-24,001
| -72% | -$674K |
|
1900
CALL
Zoetis
ZTS
$31.6B
| $265K | ﹤0.01% |
+1,600
| New | +$246K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.